Showing 13 to 24 of 28 results


Misdiagnosed Verruca Reveals Advanced Melanoma, Underscoring Rising UK Cancer Rates
A 57-year-old man's foot lesion, initially misdiagnosed as a verruca, was later revealed as stage-three malignant melanoma, highlighting challenges in melanoma diagnosis and the importance of early detection, particularly given the rising rates of this deadliest form of skin cancer in the UK.
Misdiagnosed Verruca Reveals Advanced Melanoma, Underscoring Rising UK Cancer Rates
A 57-year-old man's foot lesion, initially misdiagnosed as a verruca, was later revealed as stage-three malignant melanoma, highlighting challenges in melanoma diagnosis and the importance of early detection, particularly given the rising rates of this deadliest form of skin cancer in the UK.
Progress
28% Bias Score


Small Spot Leads to Stage 4 Melanoma Diagnosis, Nine Brain Tumors
A 42-year-old mother's seemingly harmless back spot was diagnosed as stage 4 melanoma, resulting in nine brain tumors; successful initial treatment was followed by rapid tumor regrowth, necessitating risky surgery and highlighting the aggressive nature of the disease.
Small Spot Leads to Stage 4 Melanoma Diagnosis, Nine Brain Tumors
A 42-year-old mother's seemingly harmless back spot was diagnosed as stage 4 melanoma, resulting in nine brain tumors; successful initial treatment was followed by rapid tumor regrowth, necessitating risky surgery and highlighting the aggressive nature of the disease.
Progress
48% Bias Score


Rising Melanoma Cases in Canada Highlight Sunscreen Use Concerns
A 17% rise in Canadian melanoma diagnoses in 2024 highlights inadequate sunscreen use, especially among young people who spend hours in the sun without protection, fueled by misinformation and cost; experts urge improved education and equitable access.
Rising Melanoma Cases in Canada Highlight Sunscreen Use Concerns
A 17% rise in Canadian melanoma diagnoses in 2024 highlights inadequate sunscreen use, especially among young people who spend hours in the sun without protection, fueled by misinformation and cost; experts urge improved education and equitable access.
Progress
24% Bias Score


Sun Worshipper's Cancer Warning: Surgery After Mole Neglect
Jane Murray, a 46-year-old from Dublin, underwent surgery to remove a cancerous mole resulting from years of sunbathing, highlighting the dangers of sun exposure and the importance of early diagnosis; she is now cancer-free and urging others to protect themselves.
Sun Worshipper's Cancer Warning: Surgery After Mole Neglect
Jane Murray, a 46-year-old from Dublin, underwent surgery to remove a cancerous mole resulting from years of sunbathing, highlighting the dangers of sun exposure and the importance of early diagnosis; she is now cancer-free and urging others to protect themselves.
Progress
28% Bias Score


\"Sharp Rise in Skin Cancer Diagnoses in Germany\"\
Germany is experiencing a dramatic rise in skin cancer diagnoses, with approximately 417,400 malignant melanoma cases and 1.8 million non-melanoma cases reported in 2023, attributed to an aging population, improved detection, and past inadequate sun protection practices, particularly in the 1970s an...
\"Sharp Rise in Skin Cancer Diagnoses in Germany\"\
Germany is experiencing a dramatic rise in skin cancer diagnoses, with approximately 417,400 malignant melanoma cases and 1.8 million non-melanoma cases reported in 2023, attributed to an aging population, improved detection, and past inadequate sun protection practices, particularly in the 1970s an...
Progress
36% Bias Score


Spiky Tumor Structures Identified as Key Driver of Cancer Metastasis
Scientists discovered that aggressive breast and melanoma tumors have spiky structures that facilitate cancer spread, potentially leading to new treatments that prevent metastasis by targeting these spikes.
Spiky Tumor Structures Identified as Key Driver of Cancer Metastasis
Scientists discovered that aggressive breast and melanoma tumors have spiky structures that facilitate cancer spread, potentially leading to new treatments that prevent metastasis by targeting these spikes.
Progress
40% Bias Score

Gender-Specific Melanoma Risk: New Warning Signs and Rising Rates
A new study reveals that men most commonly develop melanoma on their torso (3,700 cases yearly), while women develop it on their legs (3,200 cases yearly), highlighting the need for gender-specific awareness of less-known melanoma warning signs beyond changing moles, including nail and genital chang...

Gender-Specific Melanoma Risk: New Warning Signs and Rising Rates
A new study reveals that men most commonly develop melanoma on their torso (3,700 cases yearly), while women develop it on their legs (3,200 cases yearly), highlighting the need for gender-specific awareness of less-known melanoma warning signs beyond changing moles, including nail and genital chang...
Progress
56% Bias Score

Australian 3D Skin Cancer Scanners Fail to Improve Melanoma Detection
A $35 million Australian government investment in 15 3D full-body skin cancer scanners showed no improvement in melanoma detection compared to standard checks, raising concerns about cost-effectiveness and potential overdiagnosis, according to a JAMA Dermatology study.

Australian 3D Skin Cancer Scanners Fail to Improve Melanoma Detection
A $35 million Australian government investment in 15 3D full-body skin cancer scanners showed no improvement in melanoma detection compared to standard checks, raising concerns about cost-effectiveness and potential overdiagnosis, according to a JAMA Dermatology study.
Progress
52% Bias Score

Doctor's Melanoma Diagnosis Highlights Risks of Skin Lesions and Rare Complication
A Scottish doctor, Alastair Muir, 63, received a terminal melanoma diagnosis in 2023 after initially misidentifying a lesion on his heel. The cancer spread to his leg and pelvis, and he also developed vision-threatening melanoma-associated retinopathy. Despite a grim prognosis, he is undergoing immu...

Doctor's Melanoma Diagnosis Highlights Risks of Skin Lesions and Rare Complication
A Scottish doctor, Alastair Muir, 63, received a terminal melanoma diagnosis in 2023 after initially misidentifying a lesion on his heel. The cancer spread to his leg and pelvis, and he also developed vision-threatening melanoma-associated retinopathy. Despite a grim prognosis, he is undergoing immu...
Progress
52% Bias Score

NHS Fast-Tracks Melanoma Vaccine Access
The NHS will provide fast-tracked access to a new melanoma vaccine, iSCIB1+, for advanced melanoma patients in England, aiming to prevent recurrence and potentially saving lives; up to 10,000 patients will receive personalized cancer treatments by 2030.

NHS Fast-Tracks Melanoma Vaccine Access
The NHS will provide fast-tracked access to a new melanoma vaccine, iSCIB1+, for advanced melanoma patients in England, aiming to prevent recurrence and potentially saving lives; up to 10,000 patients will receive personalized cancer treatments by 2030.
Progress
48% Bias Score

Rostov Man's Mole Injury Leads to Melanoma Diagnosis
A 27-year-old Rostov resident's sudden seizures led to the discovery of melanoma metastases, possibly triggered by a previous mole injury; this highlights the importance of early detection and regular dermatological check-ups.

Rostov Man's Mole Injury Leads to Melanoma Diagnosis
A 27-year-old Rostov resident's sudden seizures led to the discovery of melanoma metastases, possibly triggered by a previous mole injury; this highlights the importance of early detection and regular dermatological check-ups.
Progress
52% Bias Score

Russia to Launch Personalized mRNA Cancer Vaccine in September 2025
Russia will introduce a personalized mRNA cancer vaccine for melanoma and some leukemia patients in September 2025, developed by the Gamaleya Research Institute with funding from President Putin; initial trials show promise.

Russia to Launch Personalized mRNA Cancer Vaccine in September 2025
Russia will introduce a personalized mRNA cancer vaccine for melanoma and some leukemia patients in September 2025, developed by the Gamaleya Research Institute with funding from President Putin; initial trials show promise.
Progress
64% Bias Score
Showing 13 to 24 of 28 results